New Treatment
-
Recognition for research excellence
Posted on:
Congratulations to Professor David Hunter who’s received a prestigious University of Sydney Vice Chancellor’s award for outstanding research. The Kolling researcher and rheumatology clinician is regarded as the world’s leading expert in osteoarthritis. Professor Hunter’s research has had a significant and lasting impact in the field of osteoarthritis, influencing clinical practice and access to evidence-based
-
Northern Sydney leading the way with arthritis research and clinical care
Posted on:
The latest exciting research into musculoskeletal disease has been unveiled during the inaugural Northern Lights showcase. Close to 200 people attended the jam packed event in the Kolling auditorium, including clinicians, researchers and many people living with arthritic pain. RNSH Head of Rheumatology Professor Lyn March addressed the event, detailing the devastating cost of the
Category:
-
New world leading technology to guide future bowel cancer treatment
Posted on:
Research capabilities within the Kolling Institute have been significantly broadened with new technology to assist the examination of bowel cancer. Representatives from Sydney University, the Kolling and Bowel Cancer Australia attended the official opening of the mass spectrometry core lab – the first of its type on a hospital campus and one of the best
Category:
-
New medication may offer long-acting relief for those with knee osteoarthritis
Posted on:
A study has been launched to investigate the benefits of a new injectable medication for those with knee osteoarthritis. The condition can have a profound impact on a person’s life, leading to physical limitations, ongoing pain and joint instability. There are broader implications too which can make it difficult for those with the condition to
Category:
Copyright © 2026 Kolling Institute
All rights reserved